SPAC

Groundbreaking transactions. Bold opportunities.

Decades of experience that deliver meaningful impact.

Having underwritten more SPAC deals and advised on more business combinations than any other bank, Chardan is uniquely qualified to guide you through a SPAC IPO and business combination.

As SPAC sponsors ourselves, we understand the nuances of SPAC creation and management and are here to help you succeed.

The Chardan approach to SPACs.

The right skills

Banking, transaction, sector experience and management savvy under one roof.

Proven leadership

Industry thought leaders and proprietary research covering disruptive businesses.

A winning track record

Chardan is a leader in SPACs across IPOs, business combinations and sponsor roles with 111 SPAC IPO transactions and over $14.2 billion in transaction value, including 28 business combination transactions, with over $9.8 billion in transaction value and 13 sponsored / co-sponsored SPAC transactions, with over $1.2 billion raised in transaction value.

An introduction to Chardan's approach to SPACs.

Play Video

Many possibilities, one company to get you there.

  • Sponsor

    Chardan serves as both advisor and partner in helping to both successfully raise capital through an IPO and then in identifying target acquisition candidates.

  • Merge

    Finance your growth strategy by taking your company public through a flexibly structured merger with a Special Purpose Acquisition Company (SPAC).

  • Invest

    Combine participation in high-growth, disruptive businesses with the confidence and security of cash held in trust and equity upside.

Get in touch

Healthcare SPACs

Chardan’s experience in healthcare SPACs runs deep. We pioneered the first biotech SPAC, opening the door to what is now an exploding space. With in-depth coverage across the life sciences sector, Chardan has both the buy-side relationships and deal pipeline to help you be successful. We lead with precise execution and a scientific approach that allows us to see opportunities missed by Wall Street.

Success story – Health Sciences merger with Immunovant (IMVT)

  • As of November 2020, one of the top performing SPAC transactions of all time
  • Advised on strategy and structure
  • Coordinated roadshow
  • Secured $150MM investment
  • Advised on $61MM warrant tender
  • Additional $35MM bridge for R&D
  • Participated in two post-merger follow-on transactions raising an additional $321MM

Learn more about IMVT

* 17 healthcare transactions across SPAC IPOs, business combinations and sponsor roles

17
Healthcare-focused SPACs*

* 17 healthcare transactions across SPAC IPOs, business combinations and sponsor roles

Recent Healthcare SPACs

EXPLORE OUR WORK IN  HEALTHCARE SPACS

FinTech SPACs

We’ve been deeply involved in FinTech for 20 years. Members of our team have founded, managed and successfully exited FinTech companies. Our combined SPAC product and domain expertise gives us experience on all sides of the transaction – as entrepreneurs, sponsors and investors. Through strong leadership and execution, we bring compelling FinTech SPAC opportunities to the market.

Success story – 8i Enterprises merger with Diginex

  • Advised on listing, structure and regulatory elements
  • Diginex raised more than $20 million in a convertible note, upsized from an initial target of $15 million
  • Crafted and supported key communication between investors and 8i Enterprises and Diginex throughout the SPAC M&A process
  • The merger was announced in July 2019 and closed in September 2020 with a transaction value of $317M

Learn more about Diginex

20 yrs
of FinTech experience

Recent FinTech SPACs

EXPLORE OUR WORK IN FINTECH SPACS

Cross-border SPAC Expertise

Chardan’s first sponsored SPAC in 2005 was focused in Asia and resulted in a successful business combination with a Chinese company. Since then, we’ve raised capital for 34 international SPACs IPOs, over $2.6 billion in transaction value and 19 international SPAC business combinations, over $5.9 billion in transaction value. With world-class leadership, an expansive network of global business and investor relationships, and a boots on the ground approach, we are successfully building a presence in the world’s most dynamic markets.

Success story – EdTechX Holdings merger with Meten (METX)

  • First SPAC in education services, merged with leading China-based education service company
  • Chardan served as lead coordinator for international roadshow
  • Completed $36 million private placement with global investor base
  • Closed successful transaction despite global pandemic/market turmoil in March 2020

Learn more about EdTechX

1 st SPAC
in China, Vietnam, Latin America, Africa and Eastern Europe

Recent Cross-border SPACs

EXPLORE OUR WORK IN CROSS-BORDER SPACs

Diverse Sector Experience

Our experience with disruptive businesses doesn't end with healthcare and FinTech. Chardan has carved out a leadership position across a broad range of sectors, having underwritten 46 diverse-sector SPAC IPOs, raising over $14.2 billion in transaction value. From inception through the de-SPAC, Chardan is there every step of the way. 

  • TMT
  • Industrial
  • Energy & Resources
  • Consumer
  • Education
  • And more

Success story – VectoIQ IPO (NKLA)

  • SPAC focused on automotive technology
  • Joint bookrunner on $230MM IPO
  • Acquired electric engine designer and manufacturer Nikola Motor Company (NKLA)
  • $700MM raised to fund future growth
  • Combined entity one of the most high profile SPACs

Learn more about VectoIQ

There is no sector we haven't done a deal in. Over the more than 16 years of advising and underwriting SPACs across sectors, we've seen it all.
George Kaufman
Partner, Head of Investment Banking

Recent Diverse Sector SPACs

EXPLORE OUR DIVERSE SECTOR EXPERTISE

Meet our SPAC leadership team.

Thank You!

We've received your information, and we're processing your request.

Get In Touch

17 State Street
Suite 2130
New York, NY 10004

One East Putnam Ave, 4th Fl. Greenwich, CT 06830

+1 646-465-9000

info@chardan.com

All fields required
SUBMIT